These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26354532)

  • 1. Interaction between current vitamin D supplementation and menopausal hormone therapy use on breast cancer risk: evidence from the E3N cohort.
    Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
    Am J Clin Nutr; 2015 Oct; 102(4):966-73. PubMed ID: 26354532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postmenopausal breast cancer risk and interactions between body mass index, menopausal hormone therapy use, and vitamin D supplementation: Evidence from the E3N cohort.
    Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
    Int J Cancer; 2016 Nov; 139(10):2193-200. PubMed ID: 27451078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dairy, calcium, and vitamin D intake and postmenopausal breast cancer risk in the Cancer Prevention Study II Nutrition Cohort.
    McCullough ML; Rodriguez C; Diver WR; Feigelson HS; Stevens VL; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2005 Dec; 14(12):2898-904. PubMed ID: 16365007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intake of dairy products, calcium, and vitamin d and risk of breast cancer.
    Shin MH; Holmes MD; Hankinson SE; Wu K; Colditz GA; Willett WC
    J Natl Cancer Inst; 2002 Sep; 94(17):1301-11. PubMed ID: 12208895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of postmenopausal hormone therapies and risk of histology- and hormone receptor-defined breast cancer: results from a 15-year prospective analysis of NIH-AARP cohort.
    Wang SM; Pfeiffer RM; Gierach GL; Falk RT
    Breast Cancer Res; 2020 Nov; 22(1):129. PubMed ID: 33239054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study.
    Fornili M; Perduca V; Fournier A; Jérolon A; Boutron-Ruault MC; Maskarinec G; Severi G; Baglietto L
    Breast Cancer Res; 2021 Apr; 23(1):47. PubMed ID: 33865453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary intake of vitamin D and calcium and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition.
    Abbas S; Linseisen J; Rohrmann S; Chang-Claude J; Peeters PH; Engel P; Brustad M; Lund E; Skeie G; Olsen A; Tjønneland A; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Fagherazzi G; Kaaks R; Boeing H; Buijsse B; Adarakis G; Ouranos V; Trichopoulou A; Masala G; Krogh V; Mattiello A; Tumino R; Sacerdote C; Buckland G; Suárez MV; Sánchez MJ; Chirlaque MD; Barricarte A; Amiano P; Manjer J; Wirfält E; Lenner P; Sund M; Bueno-de-Mesquita HB; van Duijnhoven FJ; Khaw KT; Wareham N; Key TJ; Fedirko V; Romieu I; Gallo V; Norat T; Wark PA; Riboli E
    Nutr Cancer; 2013; 65(2):178-87. PubMed ID: 23441605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?
    Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
    J Clin Oncol; 2009 Nov; 27(31):5138-43. PubMed ID: 19752341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin C supplement intake and postmenopausal breast cancer risk: interaction with dietary vitamin C.
    Cadeau C; Fournier A; Mesrine S; Clavel-Chapelon F; Fagherazzi G; Boutron-Ruault MC
    Am J Clin Nutr; 2016 Jul; 104(1):228-34. PubMed ID: 27194303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postmenopausal hormone use and cutaneous melanoma risk: A French prospective cohort study.
    Cervenka I; Al Rahmoun M; Mahamat-Saleh Y; Savoye I; Boutron-Ruault MC; Fournier A; Kvaskoff M
    Int J Cancer; 2019 Oct; 145(7):1754-1767. PubMed ID: 30671928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition.
    Bakken K; Fournier A; Lund E; Waaseth M; Dumeaux V; Clavel-Chapelon F; Fabre A; Hémon B; Rinaldi S; Chajes V; Slimani N; Allen NE; Reeves GK; Bingham S; Khaw KT; Olsen A; Tjønneland A; Rodriguez L; Sánchez MJ; Etxezarreta PA; Ardanaz E; Tormo MJ; Peeters PH; van Gils CH; Steffen A; Schulz M; Chang-Claude J; Kaaks R; Tumino R; Gallo V; Norat T; Riboli E; Panico S; Masala G; González CA; Berrino F
    Int J Cancer; 2011 Jan; 128(1):144-56. PubMed ID: 20232395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort.
    Fournier A; Mesrine S; Dossus L; Boutron-Ruault MC; Clavel-Chapelon F; Chabbert-Buffet N
    Breast Cancer Res Treat; 2014 Jun; 145(2):535-43. PubMed ID: 24781971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inverse associations of dietary fiber and menopausal hormone therapy with colorectal cancer risk in the Multiethnic Cohort Study.
    Park SY; Wilkens LR; Kolonel LN; Henderson BE; Le Marchand L
    Int J Cancer; 2016 Sep; 139(6):1241-50. PubMed ID: 27137137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of dietary supplements containing soy isoflavones and breast cancer risk among women aged >50 y: a prospective study.
    Touillaud M; Gelot A; Mesrine S; Bennetau-Pelissero C; Clavel-Chapelon F; Arveux P; Bonnet F; Gunter M; Boutron-Ruault MC; Fournier A
    Am J Clin Nutr; 2019 Mar; 109(3):597-605. PubMed ID: 30831601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium plus vitamin D supplementation and the risk of breast cancer.
    Chlebowski RT; Johnson KC; Kooperberg C; Pettinger M; Wactawski-Wende J; Rohan T; Rossouw J; Lane D; O'Sullivan MJ; Yasmeen S; Hiatt RA; Shikany JM; Vitolins M; Khandekar J; Hubbell FA;
    J Natl Cancer Inst; 2008 Nov; 100(22):1581-91. PubMed ID: 19001601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D and calcium intakes and breast cancer risk in pre- and postmenopausal women.
    Anderson LN; Cotterchio M; Vieth R; Knight JA
    Am J Clin Nutr; 2010 Jun; 91(6):1699-707. PubMed ID: 20392891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan.
    Kawase T; Matsuo K; Suzuki T; Hirose K; Hosono S; Watanabe M; Inagaki M; Iwata H; Tanaka H; Tajima K
    Cancer Sci; 2010 May; 101(5):1234-40. PubMed ID: 20151981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative.
    Cauley JA; Chlebowski RT; Wactawski-Wende J; Robbins JA; Rodabough RJ; Chen Z; Johnson KC; O'Sullivan MJ; Jackson RD; Manson JE
    J Womens Health (Larchmt); 2013 Nov; 22(11):915-29. PubMed ID: 24131320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of osteoporotic fractures after discontinuation of menopausal hormone therapy: results from the E3N cohort.
    Engel P; Fabre A; Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
    Am J Epidemiol; 2011 Jul; 174(1):12-21. PubMed ID: 21555715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium.
    Gaudet MM; Barrdahl M; Lindström S; Travis RC; Auer PL; Buring JE; Chanock SJ; Eliassen AH; Gapstur SM; Giles GG; Gunter M; Haiman C; Hunter DJ; Joshi AD; Kaaks R; Khaw KT; Lee IM; Le Marchand L; Milne RL; Peeters PH; Sund M; Tamimi R; Trichopoulou A; Weiderpass E; Yang XR; Prentice RL; Feigelson HS; Canzian F; Kraft P
    Breast Cancer Res Treat; 2016 Feb; 155(3):531-40. PubMed ID: 26802016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.